Cranial arteritis - An Overview: (Temporal Arteritis, Giant Cell Arteritis, also known as Horton's Arteritis);Arteriitis cranialis - Ein Überblick: (Arteriitis Temporalis Horton, Riesenzellarteriitis)

Klinische Monatsblatter fur Augenheilkunde

Volumn 220, Issue 9, 2003, Pages 579-617

  Schmidt, Dieter ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Anterior ischaemic optic neuropathy; Central retinal artery occlusion; Duplex sonography; Giant cell arteritis; Headache; Histological arterial findings

Indexed keywords

ACETYLSALICYLIC ACID; CARDIOLIPIN ANTIBODY; ENDOTHELIN 1; FLUORODEOXYGLUCOSE F 18; GADOLINIUM; GAMMA INTERFERON; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 6; METHOTREXATE; METHYLPREDNISOLONE; PHOSPHOLIPID ANTIBODY; PREDNISONE; ANTIINFLAMMATORY AGENT;

ANAMNESIS; ANTERIOR ISCHEMIC OPTIC NEUROPATHY; ARTERY; BACTERIAL ENDOCARDITIS; BLINDNESS; BLOOD VESSEL BIOPSY; BRAIN INFARCTION; CENTRAL RETINA ARTERY OCCLUSION; COLOR ULTRASOUND FLOWMETRY; DIAGNOSTIC ERROR; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; EARLY DIAGNOSIS; FACIAL ARTERY; FLUORESCENCE ANGIOGRAPHY; GIANT CELL ARTERITIS; HORNER SYNDROME; HUMAN; INDOCYANINE GREEN ANGIOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; NYSTAGMUS; OCCIPITAL ARTERY; OPHTHALMOPLEGIA; OPTIC NERVE DISEASE; POLYARTERITIS NODOSA; POSITRON EMISSION TOMOGRAPHY; PUPIL DISEASE; REVIEW; RHEUMATIC POLYMYALGIA; SYMPTOM; TEMPORAL ARTERITIS; TRANSITIONAL BLINDNESS; VERTEBRAL ARTERY; BIOPSY; DIAGNOSTIC IMAGING; EMERGENCY; EYE DISEASE; PATHOLOGY; PROGNOSIS; RISK FACTOR; TEMPORAL ARTERY; VISUAL DISORDER;

ANTI-INFLAMMATORY AGENTS; BIOPSY; BLINDNESS; DIAGNOSTIC IMAGING; EMERGENCIES; EYE DISEASES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; PROGNOSIS; RISK FACTORS; TEMPORAL ARTERIES; TEMPORAL ARTERITIS; VISION DISORDERS;

EID: 0142215298     PISSN: 00232165     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-42809     Document Type: Review

References (255)

1. Achkar AA, Lie JT, Gabriel SE, Hunder GG. Giant cell arteritis involving the facial artery. J Rheumatol 1995; 22: 360-362
2. Albert DM, Ruchman MC, Keltner JL. Skip areas in temporal arteritis. Arch Ophthalmol 1976; 94: 2072-2077
3. Allsop CJ, Gallagher PJ. Temporal artery biopsy in giant-cell arteritis. A reappraisal. Amer J Surg Pathol 1981; 5: 317-323
4. Andersen SR. Giant-cell arteritis. Horton-Magath-Brown Temporal arteritis, cranial arteritis. Trans Pac Coast Oto-Ophthalmol Soc Ann Meet 1969; 50: 35-58
5. Bacon PA, Doherty SM, Zuckerman AJ. Hepatitis-B antibody in polymyalgia rheumatica. Lancet 1975; 2: 476-478
6. Banks PM, Cohen MD, Ginsburg WW et al. Immunohistologic and cytochemical studies of temporal arteritis. Arthritis Rheumat 1983; 26: 1201-1207
7. Barbazani C, González-Gay MA, Aspe B, Fucinos L, Mantecon-Aparicio JM. Visual recovery after retinal stroke due to giant cell arteritis (Letter). Clin & Exp Rheumatol 2000; 18: 425-426
8. Barricks ME, Traviesa DB, Glaser JS, Levy IS. Ophthalmoplegia in Cranial Arteritis. Brain 1977; 100: 209-221
9. Barrier JH, Haldat du Lys F de, Billaudel S et al. Herpes zoster: serological study and cranial giant cell arteritis. J Rheumatol 1986; 13: 1190-1191
10. Barry M. The use of high-dose pulse methylprednisolone in rheumatoid arthritis. Unproved therapy. Arch Intern Med 1985; 145: 1483-1484
11. Bartolome MJ, Martínez-Taboda VM, Lopez-Hoyos M, Blanco R, Rodriguez-Valverde V. Familial aggregation of polymyalgia rheumatica and giant cell arteritis: Genetic and T cell repertoire analysis. Clin Exp Rheumatol 2001; 19: 259-264
12. Beck RW, Smith CH. Neuro-Ophthalmology: a problem-oriented approach. Boston, Toronto: Little, Brown & Comp, 1988: 53-57
13. Becourt-Verlomme C, Barouky R, Alexandre C, Gonthier R, Laurent H, Vital Durand D, Rousset H. Symptômes inauguraux de la maladie de Horton sur une série de 260 patients. Rev Méd Interne 2001; 22: 631-637
14. Bell TAG, Gibson RA, Tullo AB. A case of giant-cell arteritis and Horner's Syndrome. Scott Med J 1980; 25: 302
15. Bengtsson BÅ, Malmvall BE. Giant cell arteritis. Acta Med Scand Suppl 1982; 658: 2-102
16. Beri M, Klugman MR, Kohler JA, Hayreh SS. Anterior ischemic neuropathy. VII. Incidence of bilaterality and various influencing factors. Ophthalmology 1987; 94: 1020-1028
17. Berlit P. Clinical and laboratory findings with giant cell arteritis. J Neurol Sci 1992; 111: 1-12
18. Bevan AT, Dunnill MS, Harrison MJG. Clinical and biopsy findings in temporal arteritis. Ann Rheum Dis 1968; 27: 271-277
19. Bisgård C, Sloth H, Keiding N, Juel K. Excess mortality in giant cell arteritis. J Int Med 1991; 230: 119-123
20. Boghen DR, Glaser JS. Ischemic optic neuropathy. The clinical profile and history. Brain 1975; 98: 689-708
21. Bogousslavsky J, Deruaz JP, Regli F. Bilateral obstruction of Internal Carotid Artery from Giant-Cell Arteritis and Massive Infarction Limited to the Vertebrobasilar Area. Eur Neurol 1985; 24: 57-61
22. Bohle W, Stettin A, Jipp P. Risikofaktoren für die Entwicklung von Sehstörungen bei Polymyalgia rheumatica mit Riesenzellarteriitis. Dtsch Med Wschr 2000; 125: 681-685
23. Boyev LR, Miller NR, Green WR. Efficacy of unilateral versus bilateral temporal artery biopsies for the diagnosis of giant cell arteritis. Am J Ophthalmol 1999; 128: 211-215
24. Brack A, Martinez-Taboada V, Stanson A, Goronzy JJ, Weyand CM. Disease pattern in cranial and large-vessel giant cell arteritis. Arthritis Rheum 1999; 42: 311-317
25. Bridgeford PH, Lowenstein M, Bocanegra TS et al. Polymyalgia rheumatica and giant cell arteritis: histocompatibility typing and hepatitis-B infection studies. Arthritis Rheum 1980; 23: 516-518
26. Bronster DJ, Rudolph SH, Shanzer S. Pupillary light-near dissociation in cranial arteritis. A case report. Neuro-Ophthalmology 1983; 3: 65-70
27. Bruk MI. A comparison of the articular and vascular manifestations of polymyalgia rheumatica and giant-cell arteritis. S Afr Med J 1968; 42: 1235-1236
28. Cantalejo-Moreira M, Villaverde-García V, Villalba-Yllan A, Martín-Mola E. Multiple cerebral abscesses in a woman with giant cell arteritis (letter). Clin Exp Rheumatol 2000; 18: 267
29. Caselli RJ, Hunder GG, Whisnant JP. Neurologic disease in biopsy-proven giant cell (temporal) arteritis. Neurology 1988; 38: 352-359
30. Caselli RJ. Giant cell (temporal) arteritis: A treatable cause of multi-infarct dementia. Neurology 1990; 40: 753-755
31. Casson RJ, Fleming FK, Shaikh A, James B. Bilateral ocular ischemic syndrome secondary to giant cell arteritis. Arch Ophthalmol 2001; 119: 306-307
32. Chan CCK, Paine M, O'Day J. Steroid management in giant cell arteritis. Br J Ophthalmol 2001; 85: 1061-1064
33. Chaouat D, Benlahrache C, Yannoutsos H et al. Pseudo-polyarthrite rhizomélique et maladie de Horton. Recherche de corrélation avec le système H.L.A., le virus HB et la b 2 microglobuline. Nouv Presse Méd 1982; 11: 101-104
34. Chertok P, Leroux JL, Le Marchand M et al. Orbital pseudo-tumor in temporal arteritis revealed by computerized tomography. Clin Exp Rheumatol 1990; 8: 587-589
35. Chevalet P, Barrier JH, Pottier P, Magadur-Joly G, Pottier MA, Hamidou M, Planchon B, El Kouri D, Connan L, Dupond JL, Wazieres B de, Dien G, Duhamel E, Grosbois B, Jego P, Strat A le, Capdeville J, Letellier P, Agron L. A randomized, multicenter, controlled trial using intravenous pulses of methylprednisolone in the initial treatment of simple forms of giant cell arteritis: a one year follow up study of 164 patients. J Rheumatol 2000; 27: 1484-1491
36. Chmelewski WL, McKnight KM, Agudelo CA, Wise CM. Presenting features and outcomes in patients undergoing temporal artery biopsy. A review of 98 patients. Arch Intern Med 1992; 152: 1690-1695
37. Clearkin L, Caballero J. Recovery of visual function in anterior ischemic optic neuropathy due to giant cell arteritis. Am J Med 1992; 92: 703-704
38. Crompton MR. The visual changes in temporal (giant-cell) arteritis. Report of a case with autopsy findings. Brain 1959; 82: 377-390
39. Crompton JL, Burrow DJ, Iyer PV. Bilateral internuclear ophthalmoplegia - an unusual initial presenting sign of giant cell arteritis. Austral N Zeal J Ophthalmol 1989; 17: 71-74
40. Cullen JF. Occult temporal arteritis. A common cause of blindness in old age. Br J Ophthalmol 1967; 51: 513-525
41. Currie J, Lessell S. Tonic pupil with giant cell arteritis. Br J Ophthalmol 1984; 68: 135-138
42. Daicker B, Keller HH. Riesenzellarteriitis mit endookulärer Ausbreitung und Hypotonia bulbi dolorosa. Klin Monatsbl Augenheilkd 1971; 158: 358-372
43. Daumann C, Putz R, Schmidt D. Der Verlauf der Arteria temporalis superficialis. Anatomische Untersuchungen als Voraussetzung für eine Arterien-Biopsie. Klin Monatsbl Augenheilkd 1989; 194: 37-41
44. Diego M, Margo CE. Postural vision loss in giant cell arteritis. J Neuro-Ophthalmol 1998; 18: 124-126
45. Dimant J, Grob D, Brunner NG. Ophthalmoplegia, ptosis, and miosis in temporal arteritis. Neurology 1980; 30: 1054-1058
46. Dorra M, Piette AM, Dechy H, Betourne CI. La maladie de Horton; un diagnostic trop souvent tardif. Plaidoyer pour une biopsie précoce de l'artère temporale. Sem Hôp Paris 1984; 60: 1137-1138
47. Dot C, Hamard P, Metge F, Hamard H. Neuropathie optique ischémique aiguë bilatéralisée en 3 jours dans le cadre d'une maladie de Horton. J Fr Ophtalmol 2001; 24: 860-864
48. Doyle L, McWilliam L, Hasleton PS. Giant cell arteritis with pulmonary involvement. Br J Dis Chest 1988; 82: 88-92
49. Duhaut P, Pinède L, Demolombe-Ragué S, Loire R, Seydoux D, Ninet J, Pasquier J Groupe de Recherche sur l'artérite à cellules géantes. Giant cell arteritis and cardiovascular risk factors. A multicenter, prospective case-control study. Arthritis Rheum 1998; 41: 1960-1965
50. Duhaut P, Bosshard S, Calvet A, Pinede L, Demolombe-Ragué S, Dumontet C, Loire R, Seydoux D, Ninet J, Pasquier J, Aymard M. Giant cell arteritis, polymyalgia rheumatica, and viral hypotheses: a multicenter, prospective case-control study. J Rheumatol 1999; 26: 361-369
51. Duhaut P, Pinède L, Bornet H, Demolombe-Ragué S, Dumontet C, Ninet J, Loire R, Pasquier J GRACG (Groupe de Recherche sur l'artérite à cellules géantes). Biopsy proven and biopsy negative temporal arteritis: differences in clinical spectrum at the onset of the disease. Ann Rheum Dis 1999; 58: 335-341
52. Eagling EM, Sanders MD, Miller SJH. Ischemic papillopathy, clinical and fluorescein angiographic review of forty cases. Br J Ophthalmol 1974; 58: 990-1008
53. Ellenberger C, Keltner JL, Burde RM. Acute optic neuropathy in older patients. Arch Neurol 1973; 28: 182-185
54. Elling P, Olsson AT, Elling H. Synchronous variations of the incidence of temporal arteritis and polymyalgia rheumatica in different regions of Denmark; association with epidemics of mycoplasma pneumoniae infection. J Rheumatol 1996; 23: 112-119
55. Ellis PP, Gentry JH. Ocular complications of ulcerative colitis. Am J Ophthalmol 1964; 58: 779-785
56. Ellis JD, Munro P, McGettrick P. Blindness with a normal erythrocyte sedimentation rate in giant cell arteritis. Br J Hosp Med 1994; 52: 358-359
57. Eshaghian J. Cranial arteritis: a review of 79 cases. Stroke 1980; 11: 131
58. Espinosa G, Tàssies D, Font J, Muñoz-Rodriguez FJ, Cervera R, Ordinas A, Reverter JC, Ingelmo M. Antiphospholipid antibodies and thrombophilic factors in gient cell arteritis. Semin Arthritis Rheumatol 2001; 31: 13-20
59. Evans JM, O'Fallon WM, Hunder GG. Increased incidence of aortic aneurysm and dissection in giant cell (temporal) arteritis. Ann Intern Med 1995; 122: 502-507
60. Finelli PF. Alternating amaurosis fugax and temporal arteritis. Am J Ophthalmol 1997; 123: 850-851
61. Fisher CM. Diskussionsbemerkung zu Schlezinger NS, Schatz NJ. Giant cell arteritis (temporal arteritis). Trans Am Neurol Ass 1971; 96: 12-15
62. Fitzgerald DE, Morris LE. Temporal arteritis. A review of some current literature. J Irish Med Ass 1967; 60: 128-131
63. Fledelius HC, Nissen KR. Giant cell arteritis and visual loss. A 3-year retrospective hospital investigation in a Danish county. Acta Ophthalmol 1992; 70: 801-805
64. Font C, Cid MC, Coll-Vinent B, Lopez-Soto A, Grau JM. Clinical features in patients with permanent visual loss due to biopsy-proven giant cell arteritis. Br J Rheumatol 1997; 36: 251-254
65. Foroozan R, Danesh-Meyer HV, Savino PJ, Gamble G, Mekari-Sabbagh ON, Sergott RC. Thrombocytosis in patients with biopsy-proven giant cell arteritis. Ophthalmology 2002; 109: 1267-1271
66. Foroozan R, Buono LM, Savino PJ, Sergott RC. Tonic pupils from giant cell arteritis. Br J Ophthalmol 2003; 87: 510-512
67. Gabriel SE, O'Fallon WM, Achkar AA, Lie JT, Hunder GG. The use of clinical characteristics to predict the results of temporal artery biopsy among patients with suspected giant cell arteritis. J Rheumatol 1995; 22: 93-96
68. Gabriel SE, Espy M, Erdman DD, Bjornsson J, Smith TF, Hunder GG. The role of parvovirus B19 in the pathogenesis of giant cell arteritis. Arthritis Rheum 1999; 42: 1255-1258
69. Ghanchi FD, Weir C, Dudgeon J. Facial swelling in giant cell (temporal) arteritis. Eye 1996; 10: 747-749
70. Ghanchi FD, Dutton GN. Current concepts in giant cell (temporal) arteritis. Surv Ophthalmol 1997; 42: 99-123
71. Gibb WRG, Urry PA, Lees AJ. Giant cell arteritis with spinal cord infarction and basilar artery thrombosis. J Neurol Neurosurg Psych 1985; 48: 945-948
72. Gibbs P. Pseudotumours of the orbit. Br Med J 1974; 2: 445-446
73. Gibbs P. Temporal arteritis: onset with pseudotumour orbit or red eye. Practitioner 1974; 213: 205-211
74. Gilbert GJ. Eyeball bruits in temporal arteritis. Dis Nerv Syst 1970; 31: 130-132
75. Glutz von Blotzheim S, Borruat FX. Artérite à cellules géantes et vitesse de sédimentation normale: plus qu'un exception! Klin Monatsbl Augenheilkd 1996; 208: 397-399
76. Glutz von Blotzheim S, Borruat FX. Neuro-ophthalmic complications of biopsy-proven giant cell arteritis. Europ J Ophthalmol 1997; 7: 375-382
77. Gonzalez EB, Varner WT, Lisse JR et al. Giant-cell arteritis in the southern United States. An 11-year retrospective study from the Texas Gulf Coast. Arch Intern Med 1989; 149: 1561-1565
78. González-Gay MA, Blanco R, Rodriguez-Valverde V, Martinez-Taboada VM, Delgado-Rodriguez M, Figueroa M, Uriarte E. Permanent visual loss and cerebrovascular accidents in giant cell arteritis. Arthritis Rheum 1998; 41: 1497-1504
79. González-Gay MA, García-Porrúa C, Brañas F. Carotid occlusion mimicking giant cell arteritis (letter).J Rheumatol 1998; 25: 1247-1248
80. González-Gay MA, García-Porrúa C, Gonzálaz-Rosón O. Facial pain and giant cell arteritis (letter). J Rheumatol 1998; 25: 1242-1243
81. González-Gay MA, García-Porrúa C, Brañas F, Alba-Losada J. Giant cell arteritis presenting as occipital neuralgia (letter). Clin Exp Rheumatol 2001; 19: 479
82. Gonzálaz-Gay MA, García-Porrúa C, Llorca J, González-Louzao C, Rodriguez-Ledo P. Biopsy-negative giant cell arteritis: clinical spectrum and predictive factors for positive temporal artery biopsy. Semin Arthritis Rheum 2001; 30: 249-256
83. Gouffault J, Chevrel ML, Carrérès D Le, Bourel M. Les aspects cardiovasculaires de la maladie de Horton. Cœr Méd Interne 1969; 8: 223-230
84. Graham E. Survival in temporal arteritis. Trans Ophthal Soc U K 1980; 100: 108-110
85. Graham E, Holland A, Avery A, Ross Russell RW. Prognosis in giant-cell arteritis. Br Med J 1981; 282: 269-271
86. Gran JT, Myklebust G, Wilsgaard T, Jacobsen BK. Survival in polymyalgia rheumatica and temporal arteritis: a study of 398 cases and matched population controls. Rheumatology 2001; 40: 1238-1242
87. Guevara RA, Newman NJ, Grossniklaus H. Positive temporal artery biopsy 6 months after prednisolone treatment. Arch Ophthalmol 1998; 116: 1252-1253
88. Hachulla E, Boivin V, Pasturel-Michon U, Fauchais AL, Bouroz-Joly J, Perez-Cousin M, Hatron PY, Devulder B. Prognostic factors and long-term evolution in a cohort of 133 patients with giant cel arteritis. Clin Exp Rheumatol 2001; 19: 171-176
89. Hall S, Ginsburg WW, Vollertsen RS, Hunder GG. The coexistence of rheumatoid arthritis and giant cell arteritis. J Rheumatol 1983; 10: 995-997
90. Hall S, Hunder GG. Is temporal artery biopsy prudent? Mayo Clin Proc 1984; 59: 793-796
91. Haslbeck J. Über Augenbefunde bei Arteriitis temporalis. Bericht Dtsch Ophthalmol Ges Heidelberg 1953; 58: 339-341
92. Haugeberg G, Bie R, Nordbo SA. Chlamydia pneumoniae not detected in temporal artery biopsies from patients with temporal arteritis. Scand J Rheumatol 2000; 29: 127-128
93. Hayreh SS. Anterior Ischemic Optic Neuropathy. Berlin, Heidelberg, New York: Springer Verlag, 1975
94. Hayreh SS. Anterior ischaemic optic neuropathy. Differentiation of arteritic from non-arteritic type and management. Eye 1990; 4: 25-41
95. Hayreh SS, Podhajsky PA, Raman R, Zimmerman B. Giant cell arteritis: validity and reliability of various diagnostic criteria. Am J Ophthalmol 1997; 123: 285-296
96. Hayreh SS, Podhajsky PA, Zimmerman B. Ocular manifestations of giant cell arteritis. Am J Ophthalmol 1998; 125: 509-520
97. Hayreh SS, Podhajsky PA, Zimmerman B. Occult giant cell arteritis: ocular manifestations. Am J Ophthalmol 1998; 125: 521-526
98. Hayreh SS. Steroid therapy for visual loss in patients with giant-cell arteritis. Lancet 2000; 355: 1572-1573
99. Hayreh SS, Zimmerman B. Visual deterioration in giant cell arteritis patients while on high doses of corticosteroid therapy. Ophthalmology 2003; 110: 1204-1215
100. Hayreh SS, Zimmerman B. Management of giant cell arteritis. Our 27-year clinical study: new light on old controversies. Ophthalmologica 2003; 217: 239-259
101. Hedges TR, Gieger GL, Albert DM. The clinical value of negative temporal artery biopsy specimens. Arch Ophthalmol 1983; 101: 1251-1254
102. Helweg-Larsen J, Tarp B, Obel N, Baslund B. No evidence of parvovirus B19, Chlamydia pneumoniae or herpes virus infection in temporal artery biopsies in patients with giant cell arteritis. Rheumatology 2002; 41: 445-449
103. Hoffman GS, Cid MC, Hellmann DB, Guillevin L, Stone JH et al. A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis. Arthritis Rheum 2002; 46: 1309-1318
104. Hollenhorst RW, Brown JR, Wagener HP, Shick RM. Neurologic aspects of temporal arteritis. Neurology 1960; 10: 490-498
105. Hunder GG. Giant cell arteritis: a disease of the elderly. Geriatrics 1983; 38: 55-56, 61-62, 64
106. Hunder GG. Giant cell arteritis: improving your patient's prognosis. J Musculoskel Med 1989; 6: 94-105
107. Hunder GG, Bloch DA, Michel BA et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 1990; 33: 1122-1128
108. Hunder GG. Classification/diagnostic criteria for GCA/PMR. Clin Exp Rheumatol 2000; 18 (Suppl 20): S4-S5
109. Hunder GG. Clinical features of GCA/PMR. Clin Exp Rheumatol 2000 18 (Suppl 20): S6-S8
110. Hutnik CM, Nicolle DA, Munoz DG. Orbital aspergillose. A fatal masquerader. J Neuro-Ophthalmol 1997; 17: 257-261
111. Hutchinson EC, Yates PO. Carotico-vertebral stenosis. Lancet 1957; 1: 2-8
112. Hwang JM, Girkin CA, Perry JD, Lai JC, Miller NR, Hellmann DB. Bilateral ocular ischemic syndrome secondary to giant cell arteritis progressing despite corticosteroid treatment. Am J Ophthalmol 1999 127: 102-104
113. Jacobs RC. Polymyalgia rheumatica in an American Indian. Arthritis Rheum 1977; 20: 1429
114. Jonas JB, Gusek GC, Naumann GOH. Anterior ischemic optic neuropathy: Nonarteritic form in small and giant cell arteritis in normal sized optic discs. Int Ophthalmol 1988; 12: 119-125
115. Jonasson F, Cullen JF, Elton RA. Temporal arteritis. A 14-year epidemiological, clinical and prognostic study. Scott Med J 1979; 24: 111-117
116. Jover JA, Hernández-Garcia C, Morado IC, Vargas E, Bañares A, Fernández-Gutiérrez B. Combined treatment of giant-cell arteritis with methotrexate and prednisone. A randomized, double-blind, Placebo-controlled trial. Ann Intern Med 2001; 134: 106-114
117. Kariv R, Sidi Y, Gur H. Systemic vasculitis presenting as a tumorlike lesion. Four case reports and analysis of 79 reported cases. Medicine 2000; 79: 349-359
118. Kattah JC, Cupps T, Manz HJ, El Khodary A, Caputy A. Occipital artery biopsy: A diagnostic alternative in giant cell arteritis. Neurology 1991; 41: 949-950
119. Kattah JC, Mejico L, Chrousos GA, Zimmerman LE, Manz HJ. Pathologic findings in a steroid-responsive optic nerve infarct in giant-cell arteritis. Neurology 1999; 53: 177-180
120. Keen H. Cranial arteritis presenting as meningitis. Br Med J 1950; 1: 993-994
121. Kendall D. Some complications of temporal arteritis. Br Med J 1953; 2: 418-420
122. Kimmerling DF, Nordin PF. Cranial arteritis: a case report and discussion. Ann Intern Med 1952; 36: 1520-1526
123. Klein RG, Hunder GG, Stanson AW et al. Large artery involvement in giant cell (temporal) arteritis. Ann Intern Med 1975; 83: 806-812
124. Klein RG, Campbell RJ, Hunder GG, Carney JA. Skip lesions in temporal arteritis. Mayo Clin Proc 1976; 51: 504-510
125. Knecht S, Henningsen H, Rauterberg EW. Immunohistology of temporal arteritis: phenotyping of infiltrating cells and deposits of complement components. J Neurol 1991; 238: 181-182
126. Kollmannsberger A. Über neurologische Komplikationen der Riesenzellarteriitis (sog. Arteriitis temporalis). Münchn Med Wochenschr 1969; 111 (1): 1141-1144
127. Kupersmith MJ, Langer R, Mitnick H, Spiera R, Spiera H, Richmond M, Paget S. Visual performance in giant cell arteritis (temporal arteritis) after 1 year of therapy. Br J Ophthalmol 1999; 83: 796-801
128. Beau J Le, Taptas JN, Blatrix C. Un nouveau cas d'artérite temporale thrombosante. Artérite à cellules géantes. Bull Mém Soc Med Hôp (París) 1948; 64: 397-399
129. Lee KF, Schatz NJ. Ischemic chiasmal syndrome. Acta Radiol Suppl 1975; 347: 131-148
130. Lee AG, Eggenberger ER, Kaufman DI, Manrique C. Optic nerve enhancement on magnetic resonance imaging in arteritic ischemic optic neuropathy. J Neuro-Ophthalmol 1999; 19: 235-237
131. Lee AG. Efficacy of unilateral versus bilateral temporal artery biopsies for the diagnosis of giant cell arteritis. Am J Ophthalmol 2000; 129: 118 (letter)
132. Lee AG, Tang RA, Feldon SE, Pless M, Schiffman JS, Rubin RM, Rao N. Orbital presentations of giant cell arteritis. Graefe's Arch Clin Exp Ophthalmol 2001; 239: 509-513
133. Levine SM, Hellmann DB. Giant cell arteritis. Curr Opin Rheumatol 2002; 14: 3-10
134. Lie JT, Failoni DD, Davis DC. Temporal arteritis with giant cell aortitis, coronary arteritis, and myocardial infarction. Arch Pathol Lab Med 1986; 110: 857-860
135. Lie JT. The classification and diagnosis of vasculitis in large and medium-sized blood vessels. Pathol Annu 1987; 22: 125-162
136. Lie JT. Occidental (temporal) and oriental (Takayasu) giant cell arteritis. Cardiovasc Pathol 1994; 3: 227-240
137. Lie JT. Aortic and extracranial large vessel giant cell arteritis: a review of 72 cases with histopathologic documentation. Semin Arthritis Rheum 1995; 24: 422-431
138. Lincoff NS, Erlich PD, Brass LS. Thrombocytosis in temporal arteritis. Rising platelet counts: a red flag for giant cell arteritis. J Neuro-Ophthalmol 2000; 20: 67-72
139. Liozon F, Vidal E, Gaches F et al. Les décès dans la maladie de Horton. Facteurs de pronostic. Rev Med Interne 1992; 13: 187-191
140. Liozon E, Roblot P, Paire D, Loustaud V, Liozon F, Vidal E, Jauberteau MO. Anticardiolipin antibody levels predict flares and relapses in patients with giant-cell (temporal) arteritis. A longitudinal study of 58 biopsy-proven cases. Rheumatology 2000; 39: 1089-1094
141. Liozon E, Herrmann F, Ly K, Robert PY, Loustaud V, Soria P, Vidal E. Risk factors for visual loss in giant cell (temporal) arteritis: a prospective study of 174 patients. Am J Med 2001; 111: 211-217
142. Liozon E, Boutros-Toni F, Ly K, Loustaud-Ratti V, Soria P, Vidal E. Silent, or masked, giant cell arteritis is associated with a strong inflammatory response and a benign short term course. J Rheumtol 2003; 30: 1272-1276
143. Liu GT, Glaser JS, Schatz NJ, Smith JL. Visual morbidity in giant cell arteritis. Clinical characteristics and prognosis for vision. Ophthalmology 1994; 101: 1779-1785
144. Liu NH, LaBree LD, Feldon SE, Rao NA. The epidemiology of giant cell arteritis. A 12-year retrospective study. Ophthalmology 2001; 108: 1145-1149
145. Lotery A, Best J, Houston S. Occult giant cell (temporal) arteritis presenting with bilateral sixth and unilateral fourth nerve palsies. Eye 1998; 12: 1014-1016
146. MacDonald AB. Giant cell arteritis and Borrelia infection. J j Clin Neuro-ophthatmol 1987; 7: 180-181
147. Machado EBV, Gabriel SE, Beard CM et al. A population-based case-control study of temporal arteritis: evidence for an association between temporal arteritis and degenerative vascular disease? Int J Epidemiol 1989; 18: 836-841
148. Mack HG, O'Day J, Currie JN. Delayed choroidal perfusion in giant cell arteritis. J Clin Neuro-Ophthalmol 1991; 11: 221-227
149. Malmvall BE, Bengtsson BÅ, Kaijser B et al. Serum levels of immunoglobulin and complement in giant-cell arteritis. JAMA 1976; 236: 1876-1878
150. Malmvall BE, Bengtsson BÅ. Giant cell arteritis. Clinical features and involvement of different organs. Scand J Rheumatol 1978; 7: 154-158
151. Mambo NC. Temporal (granulomatous) arteritis: a histopathological study of 32 cases. Histopathology 1979; 3: 209-221
152. Manschot WA. A fatal case of temporal arteritis with ocular symptoms. Ophthalmologica 1965; 149: 121-130
153. Martenet AC. Fréquence et importance des symptomes oculaires dans l'artérite à cellule géantes de Horton. Oto-Neuro-Opht 1978; 50: 7-10
154. McHugh NJ, James IE, Plant GT. Anticardiolipin and antineutrophil antibodies in giant cell arteritis. J Rheumatol 1990; 17: 916-922
155. McLean CA, Gonzales MF, Dowling JP. Systemic giant cell arteritis and cerebellar infarction. Stroke 1993; 24: 899-902
156. Meadows SP. Temporal or giant cell arteritis - ophthalmic aspects. In: Smith JL (ed): Neuro-Ophthalmology. St. Louis: C. V. Mosby Company, 1968; 4: 148-157
157. Meli B, Landau K, Gloor BP. Die Tücken der Riesenzellarteriitis aus ophthalmologischer Sicht. Schweiz Med Wochenschr 1996; 126: 1821-1828
158. Mulcahy F, Juby LD, Chandler GN. Giant cell arteritis presenting with peripheral neuropathy. Postgrad Med J 1984; 60: 670-671
159. Nadeau SE. Temporal arteritis: a decision-analytic approach to temporal artery biopsy. Acta Neurol Scand 1988; 78: 90-100
160. Nordborg E, Bengtsson BÅ. Epidemiology of biopsy-proven giant cell arteritis (GCA). J Int Med 1990; 227: 233-236
161. Nordborg C, Nordborg E, Petursdottir V, LaGuardia J, Mahalingam R, Wellish M, Gilden DH. Search for varicella zoster virus in giant cell arteritis. Ann Neurol 1998; 44: 413-414
162. Nordborg E, Nordborg C, Malmvall BE, Andersson R, Nengtsson BÅ. Giant cell arteritis. Rheum Dis Clin North Am 1995; 21: 1013-1026
163. Nordborg E, Nordborg C, Petursdottir V. Giant cell arteritis. Epidemiology, etiology and pathogenesis. APMIS 2000; 108: 713-724
164. Nordborg C, Johansson H, Petursdottir V, Nordborg E.The epidemiology of biopsy-positive giant cell arteritis: special reference to changes in the age of the population, Rheumatology 2003; 42: 549-552
165. Östberg G. Morphological Changes in the large arteries in polymyalgia arteritica. Acta Med Scand 1972; 533, suppl: 135-164
166. Östberg G. On arteritis with special reference to polymyalgia arteritica. Acta Pathol Microbiol Scand Section A 1973; 237, Suppl: 1-59
167. Östberg G. Arterial lesions in polymyalgia arteritica. Path Microbiol 1975; 43: 182-186 (98-102)
168. Pache M, Kaiser HJ, Haufschild T, Lübeck P, Flammer J. Increased endothelin-1 plasma levels in giant cell arteritis: a report on four patients. Am J Ophthalmol 2002; 133: 160-162
169. Palm E. The ocular crisis of the temporal arteritis syndrome (Horton). Acta Ophthalmol 1958; 36: 208-243
170. Papaioannou CC, Trautman JC, Kazmier FJ, Hunder GG. Association of giant cell arteritis and pituitary tumor. Report of two cases. Am J Med Sci 1979; 277: 85-89
171. Peter HH. Vaskulitiden. Kapitel 38. "Klinische Immunologie" der Reihe "Innere Medizin der Gegenwart" 1991; 9: 401-414
172. Petursdottir V, Johansson H, Nordborg E, Nordborg C. The epidemiology of biopsy-positive giant cell arteritis: special reference to cyclic fluctuations. Rheumatology 1999; 38: 1208-1212
173. Pizzarello LD, MacDonald AB, Semlear Ret al. Temporal arteritis associated with Borrelia infection. A case report. J Clin Neuro-Ophthalmol 1989; 9: 3-6
174. Pless M, Rizzo JF, Lamkin JC, Lessell S. Concordance of bilateral temporal artery biopsy in giant cell arteritis. J Neuro-Ophthalmol 2000; 20: 216-218
175. Radda TM. Arteriitis temporalis Horton. Klinik, Diagnose und Pathomechanismus. Fortschr Med 1985; 103: 1073-1075
176. Rao JK, Allen NB, Pincus T. Limitations of the 1990 American College of Rheumatology classification criteria in the diagnosis of vasculitis. Ann Int Med 1998; 129: 345-352
177. Regan MJ, Wood BJ, Hsieh YH, Theodore ML, Quinn TC, Hellmann DB, Green WR, Gaydos CA, Stone JH. Temporal arteritis and Chlamydia pneumoniae. Failure to detect the organism by polymerase chain reaction in ninety cases and ninety controls. Arthritis Rheum 2002; 46: 1056-1060
178. Regouby Y, Paulus C, Pina C, Lambert de Cursay G. Maladie de Horton avec œdème facial: La "loi des séries". Presse Méd 2001; 30: 1463
179. Reinhard M, Schmidt D, Schumacher M, Hetzel A. Involvement of the vertebral arteries in giant cell arteritis mimicking vertebral dissection. J Neurol, in press
180. Reinhold-Keller E, Zeidler A, Gutfleisch J, Peter HH, Raspe HH, Gross WL. Giant cell arteritis is more prevalent in urban than in rural populations: results of an epidemiological study of primary systemic vasculitides in Germany. Rheumatology 2000; 39: 1396-1402
181. Reuther R, Betz H. Arteriitis temporalis mit ischämischer Kopfhautund Zungennekrose. Nervenarzt 1972; 43: 257-262
182. Rimenti G, Blasi F, Cosentini R, Moling O, Pristerá R, Tarsia P, Vedovelli C, Mian P. Temporal arteritis associated with Chlamydia pneumoniae DNA detected in an artery specimen. J Rheumatol 2000; 27: 2718-2720
183. Ross Russell RW. Giant-cell arteritis. A review of 35 cases. Quart J Med 1959; 28: 471-489
184. Rüegg S, Engelter S, Jeanneret C, Hetzel A, Probst A, Steck AJ, Lyrer P. Bilateral vertebral artery occlusion resulting from giant cell arteritis. Report of 3 cases and review of the literature. Medicine 2003; 82: 1-12
185. Rush JA, Kramer LD. Biopsy-negative cranial arteritis with complete oculomotor nerve palsy. Ann Ophthalmol 1979; 11: 209-213
186. Sachers F, Frey LD, Forrer A. Indikationen zur Biopsie der Arteria temporalis. Klin Monatsbl Augenheilkd 1993; 202: 373-375
187. Sadun F, Pece A, Brancato R. Fluorescein and indocyanine green angiography in arteritic anterior ischaemic optic neuropathy. Br J Ophthalmol 1998; 82: 1344-1345
188. Säve-Söderbergh J, Malmvall BE, Andersson R, Bengtsson BÅ. Giant cell arteritis as a cause of death. Report of nine cases. JAMA 1986; 255: 493-496
189. Salvarani C, Macchioni P, Boiardi L et al. Soluble interleukin 2 receptors in polymyalgia rheumatica/giant cell arteritis. Clinical and laboratory correlations. J Rheumatol 1992; 19: 1100-1106
190. Salvarani C, Hunder GG. Giant cell arteritis with low erythrocyte sedimentation rate: Frequency of occurrence in a population-based study. Arthritis Care Research 2001; 45: 140-145
191. Sanders MD. Ischaemic papillopathy. Trans Ophthalmol Soc UK 1971; 91: 369-386
192. Sawle GV, James CB, Ross Russell RW. The natural history of non-arteritic anterior ischaemic optic neuropathy. J Neurol Neurosurg Psychiatry 1990; 53: 830-833
193. Schlezinger NS, Schatz N J. Giant cell arteritis (temporal arteritis). Trans Amer Neurol Assoc 1971; 96: 12-15
194. Schmidt D, Richter T, Reutern GM von, Engelhardt R. Akute Durchblutungsstörungen des Auges. Klinische Befunde und Ergebnisse der Doppler-Sonographie der A. carotis interna. Fortschr Ophthalmol 1991; 88: 84-98
195. Schmidt D. Bulbusmassage zur Behandlung eines Zentralarterienverschlusses infolge Arteriitis temporalis (Horton). Z prakt Augenheilk 1992; 13: 21-27
196. Schmidt D. Letter to the Editor (Answer to the publication by Tomsak RL. Superficial temporal artery biopsy. A simplified technique. J Clin Neuro-ophthalmol 1991; 11: 202-204). J Clin Neuro-ophthalmol 1992; 12: 135-136
197. Schmidt D, Löffler KU. Temporal arteritis. Comparison of histological and clinical findings. Acta Ophthalmologica 1994; 72: 319-325
198. Schmidt D. Die Arteriitis temporalis Horton. Diagnose, Differenzialdiagnose, Therapie. St. Gallen, Schweiz: Elephas Buchverlag, 1995
199. Schmidt D. Arteriitis temporalis Horton. Teil 1: Symptome, klinische Diagnostik. Z prakt Augenheilk 1996; 17: 25-32
200. Schmidt D. Arteriitis temporalis Horton. Teil 2: Labordiagnostik, Therapie. Z prakt Augenheilk 1996; 17: 101-106
201. Schmidt D, Richter B. Hals-Nasen-Ohren-Befunde bei Arteriitis temporalis Horton. Literaturübersicht und Falldarstellung. HNO 1999; 47: 176-182
202. Schmidt D, Zehender M. Arterienverschluss des Auges bei infektiöser Endokarditis. Ophthalmologe 1999; 96: 264-266
203. st International Conference on Polymyalgia rheumatica and Giant Cell Arteritis. Prato/Italy, 25 - 26 May, 1999. Clin Exp Rheumatol 2000; 18 (Suppl 20): S61-S63
204. Schmidt D, Schulte-Mönting J. Letter to the Editor. Giant cell arteritis is more prevalent in urban than in rural populations. Rheumatology 2001; 40: 1193. Comment on the article by Reinhold-Keller et al. Rheumatology 2000; 39: 1396-1402
205. Schmidt D, Schulte-Mönting J. Letter to the Editor. Giant cell arteritis is more prevalent in urban than in rural populations. Rheumatology 2001; 40: 1193. Comment on the article by Reinhold-Keller et al. Rheumatology 2000; 39: 1396-1402
206. Schmidt D, Adelmann G. The course of the occipital artery - an anatomical investigation for biopsy in suspected vasculitis. Europ J Med Res 2001; 6: 235-241
207. Schmidt D. Fehlbeurteilung eines Arterienastverschlusses. Tübingen: 85. Tagung der Württembergischen Augenärztlichen Vereinigung 24./25.3.2001, (gedruckt im Internet der Univ.-Augenklinik Tübingen)
208. Schmidt D, Lagrèze W, Vaith P. Ophthalmoskopischer Befund bei 3 Patienten mit Panarteriitis nodosa und Literaturübersicht. Klin Monatsbl Augenheilkd 2001; 218: 44-50
209. Schmidt D, Hetzel A, Reinhard M, Auw-Haedrich C. Comparison between color duplex ultrasonography and histology of the temporal artery in cranial arteritis (giant cell arteritis). Eur J Med Res 2003; 8: 1-7
210. Schmidt WA, Kraft HE, Vorpahl K, Völker L, Gromnica-Ihle EJ. Color duplex ultrasonography in the diagnosis of temporal arteritis. N Engl J Med 1997; 337: 1336-1342
211. Schmidt WA, Gromnica-Ihle E. Incidence of temporal arteritis in patients with polymyalgia rheumatica: a prospective study using colour Doppler ultrasonography of the temporal arteries. Rheumatology 2002; 41: 46-52
212. Scott GI. Optic disc oedema. Trans Ophthal Soc UK 1968; 87: 733-753
213. Scott KR, Tse DT, Kronish JW. Temporal artery biopsy technique: a clinico-anatomical approach. Ophth Surg 1991; 22: 519-525
214. Seitz R. Die Riesenzellarteriitis als Ursache akuter Erblindung. Klin Monatsbl Augenheilkd 1958; 132: 383-403
215. Shah P, Murray PI, Harry J. An unusual case of giant cell arteritis. Am J Ophthalmol 1993; 115: 393-394
216. Shults WT. Ischemic optic neuropathy. Still the ophthalmologist's dilemma. Ophthalmology 1984; 91: 1338-1341
217. Siatkowski RM, Gass JD, Glaser JS, Smith JL, Schatz NJ, Schiffman J. Fluorescein angiography in the diagnosis of giant cell arteritis. Am J Ophthalmol 1993; 115: 57-63
218. Slavin ML. Brow droop after superficial temporal artery biopsy. Arch Ophthalmol 1986; 104: 1127
219. Smith CA, Fidler WJ, Pinals RS. The epidemiology of giant cell arteritis. Report of a ten-year study in Shelby County, Tennessee. Arthritis Rheum 1983; 26: 1214-1219
220. Soelberg-Sørensen·P, Lorenzen I. Giant-cell arteritis, temporal arteritis and polymyalgia rheumatica. A retrospective study of 63 patients. Acta Med Scand 1977; 201: 207-213
221. Sonnenblick M, Nesher G, Rosin A. Nonclassical organ involvement in temporal arteritis. Sem Arthritis Rheum 1989; 19: 183-190
222. Spetzler RF, Hadley MN et al. Vertebrobasilar insufficiency. J Neurosurg 1987; 66: 648-661
223. Spiera RF, Mitnick HJ, Kupersmith M, Richmond M, Spiera H, Peterson MGE, Paget SA. A prospective, double-blind, randomized, placebo controlled trial of methotrexate in the treatment of giant cell arteritis. Clin Exp Rheumatol 2001; 19: 495-501
224. Strempel I, Fritzsche R. Arteriitis temporalis - eine retrospektive Studie. Fortschr Ophthalmol 1987; 84: 364-366
225. Thomson GTD, Johnston JL, Sharpe JA, Inman RD. Internuclear ophthalmoplegia in giant cell arteritis. J Rheumatol 1989; 16: 693-695
226. Thystrup J, Knudsen GM, Mogensen AM, Fledelius HC. Atypical visual loss in giant cell arteritis. Acta Ophthalmol 1994; 72: 759-764
227. Trend P, Graham E. Internuclear ophthalmoplegia in giant-cell arteritis. J Neurol Neurosurg Psychiatry 1990; 53: 532-533
228. Turlakow A, Yeung HWD, Pui J, Macapinlac H, Liebovitz E, Rusch V, Goy A, Larson SM. Fludeoxyglucose positron emission tomography in the diagnosis of giant cell arteritis. Arch Intern Med 2001; 161: 1003-1007
229. Uddhammar A, Eriksson AL, Nyström L, Stenling R, Rantapää-Dahlqvist S. Increased mortality due to cardiovascular disease in patients with giant cell arteritis in northern Sweden. J Rheumatol 2002; 29: 737-742
230. Vaith P et al. Polymyalgia rheumatica nach Borrelieninfektion. Immun Infekt 1988; 16: 71-73
231. Valmaggia C, Speiser P, Bischoff P, Niederberger H. Indocyanine green versus fluorescein angiography in the differential diagnosis of arteritic and nonarteritic anterior ischemic optic neuropathy. Retina 1999; 19: 131-134
232. Vollrath-Junger C, Gloor B. Warum eine Doppler-Sonographie vor jeder Biopsie der A. temporalis? Klin Monatsbl Augenheilkd 1989; 195: 169-171
233. Wagener HP, Hollenhorst RW. The ocular lesions of temporal arteritis. Trans. Am Ophthalm Soc 1957; 55: 249-273
234. Wagner AD, Gérard HC, Fresemann T, Schmidt WA, Gromnica-Ihle E, Hudson AP, Zeidler H. Detection of Chlamydia pneumoniae in giant cell vasculitis and correlation with the topographic arrangement of tissue-infiltrating dendritic cells. Arthritis Rheum 2000; 43: 1543-1551
235. Walsh FB, Hoyt WF. Giant Cell Arteritis: Arteritis of the Aged (Temporal Arteritis, Cranial Arteritis, Polymyalgia Rheumatica); 1878-1886. In: Clinical Neuro-Ophthalmology. Baltimore: Williams & Wilkins, 1969
236. Watts MT, Greaves M, Rennie IG, Clearkin LG. Antiphospholipid antibodies in the aetiology of ischaemic optic neuropathy. Eye 1991; 5: 75-79
237. Weems JJ. Diagnosis of giant cell arteritis by occipital artery biopsy. Am J Med 1992; 93: 231-232
238. Wells KK, Folberg R, Goeken JA, Kemp JD. Temporal artery biopsies. Correlation of light microscopy and immunofluorescence microscopy. Ophthalmology 1989; 96: 1058-1064
239. Wenkel H. Bilaterale Amaurose bei 11 Patienten mit histologisch gesicherter Riesenzellarteriitis. Klin Monatsbl Augenheilkd 2001; 218: 658-661
240. Weyand CM, Hicok KC, Hunder GG, Goronzy JJ. The HLA-DRB 1 locus as a genetic component in giant cell arteritis. Mapping of a disease-linked sequence motif to the.antigen binding site of the HLA-DR molecule. J Clin Invest 1992; 90: 2355-2361
241. Weyand CM, Hunder NNH, Hicok KC et al. HLA-DRB1 alleles in polymyalgia rheumatica, giant cell arteritis, and rheumatoid arthritis. Arthritis Rheum 1994; 37: 514-520
242. Weyand CM, Goronzy JJ. Arterial wall injury in giant cell arteritis. Arthritis Rheum 1999; 42: 844-853
243. Weyand CM. The pathogenesis of giant cell arteritis. J Rheumatol 2000; 27: 517-522
244. Weyand CM, Fulbright JW, Hunder GG, Evans JM, Goronzy JJ. Treatment of giant cell arteritis. Interleukin-6 as a biologic marker of disease activity. Arthritis Rheum 2000; 43: 1041-1048
245. Weyand CM, Kaiser M, Yang H, Younge B, Goronzy JJ. Therapeutic effects of acetylsalicylic acid in giant cell arteritis. Arthritis Rheum 2002; 46: 457-466
246. Wiggins RE. Invasive aspergillose. A complication of treatment of temporal arteritis. J Neuro-Ophthalmol 1995; 15: 36-38
247. Wilcox JN, Scott NA. Potential role of the adventitia in arteritis and atherosclerosis. Int J Cardiol 1996; 54, Suppl: 21-35
248. Wilhelm H. Pupillotonie durch Ischämie. Fortschr Ophthalmol 1989; 86: 380-382
249. Wilkinson IMS. The vertebral artery. Extracranial and intracranial structure. Arch Neurol 1972; 27: 392-396
250. Wilkinson IMS, Russell RWR. Arteries of the head and neck in giant cell arteritis. A pathological study to show the pattern of arterial involvement. Arch Neurol 1972; 27: 378-391
251. Wilske KR, Healey LA. Clinical manifestations of biopsy-proven giant cell arteritis. Arthritis Rheum 1971; 14: 424
252. Wollensak J. Arteriitis temporalis. In: Bücherei des Augenarztes. 1981; Heft 87. Stuttgart: F. Enke-Verlag,
253. Wyble M, Schimek RA. The simultaneous occurrence of two collagen diseases in the same patient. Trans Am Acad Ophthalmol Otolaryngol 1962; 66: 632-691
254. Wykes WN, Cullen JF. Headache and temporal arteritis. Scott Med J 1985; 30: 42
255. Youinou PY, Pennec Y, Tande D, Menn G le. Immune complexes and autoantibodies in patients with giant cell arteritis and their relationship with autologous rosette-forming cells. Clin Exp Rheumatol 1985; 3: 17-21